Patent · US Active

Intrauterine delivery system for contraception

US10532025B2 · kind B2 · utility

3Cited by

3References

21Claims

0Family size

Assignee

Bayer Oy · FI

Inventors

Bernd Duesterberg · Velten, DE
Manja Ahola · Turku, FI
Jyrki Pihlaja · Paimio, FI
Heikki Lyytikäinen · Naantali, FI
Harri Jukarainen · Kuusisto, FI
Satu Kleemola · Naantali, FI
Tero Parkatti · Turku, FI
Tuula Valo · Turku, FI
Ina Gröticke · Berlin, DE
Bernhard Lindenthal · Berlin, DE
Ulrike Fuhrmann · Berlin, DE

Key dates

Filing date	May 18, 2018
Grant date	Jan 14, 2020
Priority date	—
Expiry date	May 18, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for contraception and for reducing menstrual problems and inducing amenorrhea, wherein an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.